101
|
Reiss N, Schmidt T, Feldmann C, Deniz E, Mommertz S, Haverich A, Willemsen D, Schmitto J. Different Indications for Inert Gas Rebreathing in the Management of LVAD Patients. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
102
|
Deniz E, Feldmann C, Schmidt T, Hoffmann J, Hanke J, Rojas-Hernandez S, Dogan G, Berliner D, Bara C, Warnecke G, Haverich A, Schmitto J, Reiss N. The Impact of Telemonitoring in Patients with Ventricular Assist Device. Thorac Cardiovasc Surg 2017. [DOI: 10.1055/s-0037-1598927] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
103
|
Domenech K, Calkins CR, Chao MD, Buntyn J, Schmidt T. Impact of Supplementing Cattle with Omnigen-AF at the Receiving or Fin-ishing Phase on Beef Shelf-Life. MEAT AND MUSCLE BIOLOGY 2017. [DOI: 10.22175/rmc2016.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
104
|
Balzani D, Schmidt T, Ortiz M. Method for the quantification of rupture probability in soft collagenous tissues. INTERNATIONAL JOURNAL FOR NUMERICAL METHODS IN BIOMEDICAL ENGINEERING 2017; 33:e02781. [PMID: 26929160 DOI: 10.1002/cnm.2781] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/24/2015] [Revised: 01/29/2016] [Accepted: 02/22/2016] [Indexed: 06/05/2023]
Abstract
A computational method is presented for the assessment of rupture probabilities in soft collagenous tissues. This may in particular be important for the quantitative analysis of medical diseases such as atherosclerotic arteries or abdominal aortic aneurysms, where an unidentified rupture has in most cases fatal consequences. The method is based on the numerical minimization and maximization of probabilities of failure, which arise from random input quantities, for example, tissue properties. Instead of assuming probability distributions for these quantities, which are typically unknown especially for soft collagenous tissues, only restricted knowledge of these distributions is taken into account. Given this limited statistical input data, the minimized/maximized probabilities represent optimal bounds on the rupture probability, which enable a quantitative estimation of potential risks of performing or not performing medical treatment. Although easily extendable to all kinds of mechanical rupture criteria, the approach presented here incorporates stretch-based and damage-based criteria. These are evaluated based on numerical simulations of loaded tissues, where continuum mechanical material formulations are considered, which capture the supra-physiological behavior of soft collagenous tissues. Numerical examples are provided demonstrating the applicability of the method in an overstretched atherosclerotic artery. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
|
105
|
Spink C, Avanesov M, Schmidt T, Grass M, Schoen G, Adam G, Bannas P, Koops A. Radiation dose reduction during transjugular intrahepatic portosystemic shunt implantation using a new imaging technology. Eur J Radiol 2016; 86:284-288. [PMID: 28027761 DOI: 10.1016/j.ejrad.2016.11.028] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2016] [Revised: 11/15/2016] [Accepted: 11/23/2016] [Indexed: 02/07/2023]
Abstract
OBJECTIVE To compare patient radiation dose in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS) implantation before and after an imaging-processing technology upgrade. METHODS In our retrospective single-center-study, cumulative air kerma (AK), cumulative dose area product (DAP), total fluoroscopy time and contrast agent were collected from an age- and BMI-matched collective of 108 patients undergoing TIPS implantation. 54 procedures were performed before and 54 after the technology upgrade. Mean values were calculated and compared using two-tailed t-tests. Two blinded, independent readers assessed DSA image quality using a four-rank likert scale and the Wilcoxcon test. RESULTS The new technology demonstrated a significant reduction of 57% of mean DAP (402.8 vs. 173.3Gycm2, p<0.001) and a significant reduction of 58% of mean AK (1.7 vs. 0.7Gy, p<0.001) compared to the precursor technology. Time of fluoroscopy (26.4 vs. 27.8min, p=0.45) and amount of contrast agent (109.4 vs. 114.9ml, p=0.62) did not differ significantly between the two groups. The DSA image quality of the new technology was not inferior (2.66 vs. 2.77, p=0.56). CONCLUSIONS In our study the new imaging technology halved radiation dose in patients undergoing TIPS maintaining sufficient image quality without a significant increase in radiation time or contrast consumption.
Collapse
|
106
|
Oehler N, Schmidt T, Niemeier A. [Total Joint Replacement and Return to Sports]. SPORTVERLETZUNG-SPORTSCHADEN 2016; 30:195-203. [PMID: 27984831 DOI: 10.1055/s-0042-119109] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Background: An increasing number of physically active patients not only need to know if they will basically be able to engage in sports after undergoing arthroplasty. They also would like to know whether or not they will be able to resume their preoperative activity levels. This article aims to provide an overview of recent data regarding the following questions on hip, knee and shoulder arthroplasty: (1) What is the impact of physical activity on an endoprosthesis? (2) What level of sports can be achieved after an arthroplasty procedure? (3) What types of sport are recommended for patients with an endoprosthesis? Methods: PubMed-based review of the literature. Narrative review focusing on current data from the years 2010 to 2016. Results: The commonly known recommendation to exercise low-impact sports such as hiking, swimming, cycling or golf at a moderate intensity remains valid for all types of prostheses in all joints. There is broad consensus that the benefits of these sports outweigh the negative effects. Having undergone total hip or knee arthroplasty, most patients with a high preoperative activity level return to sports after 3-6 months, albeit with a clear tendency to lower intensity and a shift from high-impact to low-impact sports. Some key questions have to be answered regarding the effects of low-impact sports that are exercised with high intensity, the effects resulting from high-impact sports, effects specific to different types of sport, and possibilities provided by different prosthesis types. In this context, a lot remains to be done to investigate the limits between positive and negative effects resulting from physical activity of varying intensity. New data suggests that generally a higher physical performance level may be achieved than has been traditionally recommended. Early results of unicondylar knee prostheses are far better than those achieved with bicondylar prostheses. In contrast to expert recommendations, shoulder endoprostheses show the highest postoperative activity levels after inverted arthroplasty, followed by anatomic arthroplasty, and the lowest activity level after the implantation of a hemiprosthesis. Conclusion: There is a significant discrepancy between previous expert recommendations and the actual activity levels that may be achieved after the implantation of a joint prosthesis. Future studies have to define the sports level, the type of sports and the type of prosthesis that provide a positive benefit-risk ratio using state-of-the-art low-abrasion bearing surfaces and prosthesis designs.
Collapse
|
107
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Archinger M, Argüelles C, Auffenberg J, Axani S, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blot S, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Burgman A, Carver T, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin GH, Conrad JM, Cowen DF, Cross R, Day M, de André JPAM, De Clercq C, Del Pino Rosendo E, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Eller P, Euler S, Evenson PA, Fahey S, Fazely AR, Feintzeig J, Felde J, Filimonov K, Finley C, Flis S, Fösig CC, Franckowiak A, Friedman E, Fuchs T, Gaisser TK, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Gladstone L, Glagla M, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Grant D, Griffith Z, Haack C, Haj Ismail A, Hallgren A, Halzen F, Hansen E, Hansmann B, Hansmann T, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfel K, Hoshina K, Huang F, Huber M, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Jurkovic M, Kappes A, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kemp J, Kheirandish A, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein SR, Kohnen G, Koirala R, Kolanoski H, Konietz R, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Krüger C, Kunnen J, Kunwar S, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lauber F, Lennarz D, Lesiak-Bzdak M, Leuermann M, Leuner J, Lu L, Lünemann J, Madsen J, Maggi G, Mahn KBM, Mancina S, Mandelartz M, Maruyama R, Mase K, Maunu R, McNally F, Meagher K, Medici M, Meier M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Mohrmann L, Montaruli T, Moulai M, Nahnhauer R, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, O'Murchadha A, Palczewski T, Pandya H, Pankova DV, Penek Ö, Pepper JA, Pérez de Los Heros C, Pieloth D, Pinat E, Price PB, Przybylski GT, Quinnan M, Raab C, Rädel L, Rameez M, Rawlins K, Reimann R, Relethford B, Relich M, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Sabbatini L, Sanchez Herrera SE, Sandrock A, Sandroos J, Sarkar S, Satalecka K, Schimp M, Schlunder P, Schmidt T, Schoenen S, Schöneberg S, Schumacher L, Seckel D, Seunarine S, Soldin D, Song M, Spiczak GM, Spiering C, Stahlberg M, Stanev T, Stasik A, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Tatar J, Tenholt F, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Toscano S, Tosi D, Tselengidou M, Turcati A, Unger E, Usner M, Vandenbroucke J, van Eijndhoven N, Vanheule S, van Rossem M, van Santen J, Veenkamp J, Vehring M, Voge M, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Weaver C, Weiss MJ, Wendt C, Westerhoff S, Whelan BJ, Wickmann S, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wills L, Wolf M, Wood TR, Woolsey E, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zoll M. Constraints on Ultrahigh-Energy Cosmic-Ray Sources from a Search for Neutrinos above 10 PeV with IceCube. PHYSICAL REVIEW LETTERS 2016; 117:241101. [PMID: 28009216 DOI: 10.1103/physrevlett.117.241101] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/14/2016] [Indexed: 06/06/2023]
Abstract
We report constraints on the sources of ultrahigh-energy cosmic rays (UHECRs) above 10^{9} GeV, based on an analysis of seven years of IceCube data. This analysis efficiently selects very high- energy neutrino-induced events which have deposited energies from 5×10^{5} GeV to above 10^{11} GeV. Two neutrino-induced events with an estimated deposited energy of (2.6±0.3)×10^{6} GeV, the highest neutrino energy observed so far, and (7.7±2.0)×10^{5} GeV were detected. The atmospheric background-only hypothesis of detecting these events is rejected at 3.6σ. The hypothesis that the observed events are of cosmogenic origin is also rejected at >99% CL because of the limited deposited energy and the nonobservation of events at higher energy, while their observation is consistent with an astrophysical origin. Our limits on cosmogenic neutrino fluxes disfavor the UHECR sources having a cosmological evolution stronger than the star formation rate, e.g., active galactic nuclei and γ-ray bursts, assuming proton-dominated UHECRs. Constraints on UHECR sources including mixed and heavy UHECR compositions are obtained for models of neutrino production within UHECR sources. Our limit disfavors a significant part of parameter space for active galactic nuclei and new-born pulsar models. These limits on the ultrahigh-energy neutrino flux models are the most stringent to date.
Collapse
|
108
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Andeen K, Anderson T, Ansseau I, Anton G, Archinger M, Argüelles C, Arlen TC, Auffenberg J, Axani S, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Becker Tjus J, Becker KH, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Blaufuss E, Blot S, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Burgman A, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Clark K, Classen L, Coenders S, Collin GH, Conrad JM, Cowen DF, Cruz Silva AH, Daughhetee J, Davis JC, Day M, de André JPAM, De Clercq C, Del Pino Rosendo E, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, di Lorenzo V, Dujmovic H, Dumm JP, Dunkman M, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fahey S, Fazely AR, Feintzeig J, Felde J, Filimonov K, Finley C, Flis S, Fösig CC, Fuchs T, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Giang W, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Góra D, Grant D, Griffith Z, Haj Ismail A, Hallgren A, Halzen F, Hansen E, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfel K, Homeier A, Hoshina K, Huang F, Huber M, Huelsnitz W, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jeong M, Jero K, Jones BJP, Jurkovic M, Kappes A, Karg T, Karle A, Katz U, Kauer M, Keivani A, Kelley JL, Kheirandish A, Kim M, Kintscher T, Kiryluk J, Kittler T, Klein SR, Kohnen G, Koirala R, Kolanoski H, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll M, Krückl G, Krüger C, Kunnen J, Kunwar S, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lennarz D, Lesiak-Bzdak M, Leuermann M, Lu L, Lünemann J, Madsen J, Maggi G, Mahn KBM, Mancina S, Mandelartz M, Maruyama R, Mase K, Maunu R, McNally F, Meagher K, Medici M, Meier M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Middell E, Mohrmann L, Montaruli T, Moulai M, Nahnhauer R, Naumann U, Neer G, Niederhausen H, Nowicki SC, Nygren DR, Obertacke Pollmann A, Olivas A, Omairat A, O'Murchadha A, Palczewski T, Pandya H, Pankova DV, Pepper JA, Pérez de Los Heros C, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Quinnan M, Raab C, Rameez M, Rawlins K, Relich M, Resconi E, Rhode W, Richman M, Riedel B, Robertson S, Rott C, Ruhe T, Ryckbosch D, Rysewyk D, Sabbatini L, Salvado J, Sanchez Herrera SE, Sandrock A, Sandroos J, Sarkar S, Satalecka K, Schlunder P, Schmidt T, Schöneberg S, Schönwald A, Seckel D, Seunarine S, Soldin D, Song M, Spiczak GM, Spiering C, Stamatikos M, Stanev T, Stasik A, Steuer A, Stezelberger T, Stokstad RG, Stößl A, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Tatar J, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Toscano S, Tosi D, Tselengidou M, Turcati A, Unger E, Usner M, Vallecorsa S, Vandenbroucke J, van Eijndhoven N, Vanheule S, van Rossem M, van Santen J, Veenkamp J, Voge M, Vraeghe M, Walck C, Wallace A, Wandkowsky N, Weaver C, Wendt C, Westerhoff S, Whelan BJ, Wiebe K, Wille L, Williams DR, Wills L, Wissing H, Wolf M, Wood TR, Woolsey E, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zoll M. Searches for Sterile Neutrinos with the IceCube Detector. PHYSICAL REVIEW LETTERS 2016; 117:071801. [PMID: 27563950 DOI: 10.1103/physrevlett.117.071801] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/05/2016] [Indexed: 06/06/2023]
Abstract
The IceCube neutrino telescope at the South Pole has measured the atmospheric muon neutrino spectrum as a function of zenith angle and energy in the approximate 320 GeV to 20 TeV range, to search for the oscillation signatures of light sterile neutrinos. No evidence for anomalous ν_{μ} or ν[over ¯]_{μ} disappearance is observed in either of two independently developed analyses, each using one year of atmospheric neutrino data. New exclusion limits are placed on the parameter space of the 3+1 model, in which muon antineutrinos experience a strong Mikheyev-Smirnov-Wolfenstein-resonant oscillation. The exclusion limits extend to sin^{2}2θ_{24}≤0.02 at Δm^{2}∼0.3 eV^{2} at the 90% confidence level. The allowed region from global analysis of appearance experiments, including LSND and MiniBooNE, is excluded at approximately the 99% confidence level for the global best-fit value of |U_{e4}|^{2}.
Collapse
|
109
|
Webster JM, Schmidt T, Mew J. A Holographic Interferometric Technique for the Detection and Computerized Recognition of Structural Faults in Semi-Monocoque Structures. THE IMAGING SCIENCE JOURNAL 2016. [DOI: 10.1080/13682199.1998.11736438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
110
|
Müller B, Schmidt T, Guntinas-Lichius O. Die Schwellen-BERA in Narkose. Laryngorhinootologie 2016; 95:380-1. [DOI: 10.1055/s-0042-108222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
111
|
Schott D, Schmidt T, Chen X, Klawikowski S, Noid G, Dalah E, Li X. SU-D-202-03: Statistical Segmentation On Quantitative CT for Assessing Spatial Tumor Response During Radiation Therapy Delivery. Med Phys 2016. [DOI: 10.1118/1.4955643] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
112
|
Sester M, Leboeuf C, Schmidt T, Hirsch HH. The "ABC" of Virus-Specific T Cell Immunity in Solid Organ Transplantation. Am J Transplant 2016; 16:1697-706. [PMID: 26699950 DOI: 10.1111/ajt.13684] [Citation(s) in RCA: 69] [Impact Index Per Article: 8.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2015] [Revised: 12/07/2015] [Accepted: 12/08/2015] [Indexed: 01/25/2023]
Abstract
Transplant patients are at increased risk of viral complications due to impaired control of viral replication, resulting from HLA mismatching between graft and host and the immunosuppression needed to avert alloimmune reactions. In the past decade, quantitative viral load measurements have become widely available to identify patients at risk and to inform treatment decisions with respect to immunosuppressive drugs and antiviral therapies. Because viral loads are viewed as the result of viral replication and virus-specific immune control, virus-specific T cell monitoring has been explored to optimize management of adenovirus, BK polyomavirus and cytomegalovirus ("ABC") in transplant patients. Although most studies are descriptive using different technologies, the overall results show that the quantity and quality of virus-specific T cells inversely correlate with viral replication, whereby strong cellular immune responses are associated with containment of viral replication. The key obstacles to the introduction of assays for virus-specific T cells into clinical practice is the definition of reliable cutoffs for clinical decision making, the poor negative predictive value of some assays, and the absence of interventional trials justifying changes of antiviral treatment or immunosuppression. More clinical research is needed using optimized assays and targets before standardization and commutability can be envisaged as achieved for viral load testing.
Collapse
|
113
|
Kuhlmann A, Schmidt T, Treskova M, López-Bastida J, Linertová R, Oliva-Moreno J, Serrano-Aguilar P, Posada-de-la-Paz M, Kanavos P, Taruscio D, Schieppati A, Iskrov G, Péntek M, Delgado C, von der Schulenburg JM, Persson U, Chevreul K, Fattore G. Social/economic costs and health-related quality of life in patients with juvenile idiopathic arthritis in Europe. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS : HEPAC : HEALTH ECONOMICS IN PREVENTION AND CARE 2016; 17 Suppl 1:79-87. [PMID: 27086322 DOI: 10.1007/s10198-016-0786-1] [Citation(s) in RCA: 37] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/25/2015] [Accepted: 01/13/2016] [Indexed: 06/05/2023]
Abstract
OBJECTIVE The aim of this study was to determine the economic burden from a societal perspective and the health-related quality of life (HRQOL) of patients with juvenile idiopathic arthritis (JIA) in Europe. METHODS We conducted a cross-sectional study of patients with JIA from Germany, Italy, Spain, France, the United Kingdom, Bulgaria, and Sweden. Data on demographic characteristics, healthcare resource utilization, informal care, labor productivity losses, and HRQOL were collected from the questionnaires completed by patients or their caregivers. HRQOL was measured with the EuroQol 5-domain (EQ-5D-5L) questionnaire. RESULTS A total of 162 patients (67 Germany, 34 Sweden, 33 Italy, 23 United Kingdom, 4 France, and 1 Bulgaria) completed the questionnaire. Excluding Bulgarian results, due to small sample size, country-specific annual health care costs ranged from €18,913 to €36,396 (reference year: 2012). Estimated direct healthcare costs ranged from €11,068 to €22,138; direct non-healthcare costs ranged from €7837 to €14,155 and labor productivity losses ranged from €0 to €8715. Costs are also shown to differ between children and adults. The mean EQ-5D index score for JIA patients was estimated at between 0.44 and 0.88, and the mean EQ-5D visual analogue scale score was estimated at between 62 and 79. CONCLUSIONS JIA patients incur considerable societal costs and experience substantial deterioration in HRQOL in some countries. Compared with previous studies, our results show a remarkable increase in annual healthcare costs for JIA patients. Reasons for the increase are the inclusion of non-professional caregiver costs, a wider use of biologics, and longer hospital stays.
Collapse
|
114
|
Reiss N, Schmidt T, Mommertz S, Altesellmeier M, Willemsen D, Schulte-Eistrup S. The Role of Inertgas-Rebreathing Method During Exercise Testing in LVAD Patients. J Heart Lung Transplant 2016. [DOI: 10.1016/j.healun.2016.01.1112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
115
|
Willemsen D, Cordes C, Bjarnason-Wehrens B, Knoglinger E, Langheim E, Marx R, Reiss N, Schmidt T, Workowski A, Bartsch P, Baumbach C, Bongarth C, Phillips H, Radke R, Riedel M, Schmidt S, Skobel E, Toussaint C, Glatz J. [Rehabilitation standards for follow-up treatment and rehabilitation of patients with ventricular assist device (VAD)]. Clin Res Cardiol Suppl 2016; 11 Suppl 1:2-49. [PMID: 26882905 DOI: 10.1007/s11789-015-0077-x] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
The increasing use of ventricular assist devices (VADs) in terminal heart failure patients provides new challenges to cardiac rehabilitation physicians. Structured cardiac rehabilitation strategies are still poorly implemented for this special patient group. Clear guidance and more evidence for optimal modalities are needed. Thereby, attention has to be paid to specific aspects, such as psychological and social support and education (e.g., device management, INR self-management, drive-line care, and medication).In Germany, the post-implant treatment and rehabilitation of VAD Patients working group was founded in 2012. This working group has developed clear recommendations for the rehabilitation of VAD patients according to the available literature. All facets of VAD patients' rehabilitation are covered. The present paper is unique in Europe and represents a milestone to overcome the heterogeneity of VAD patient rehabilitation.
Collapse
|
116
|
Thielsen T, Frerker C, Schmidt T, Schlüter M, Kreidel F, Alessandrini H, Kuck KH. [Future interventional procedures for valve diseases]. Internist (Berl) 2016; 57:341-8. [PMID: 26907869 DOI: 10.1007/s00108-016-0029-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
BACKGROUND Percutaneous valve therapies represent one of the most innovative areas within interventional cardiology in the past 10 years. AIM The aim of this work is to give an overview of current and upcoming therapeutic options. MATERIALS AND METHODS In this manuscript, the results of a retro- and prospective literature research are summarized. RESULTS AND DISCUSSION With the introduction of percutaneous therapies for valvular heart disease, patients who were previously considered too ill for surgery can now be treated. The percutaneous treatment of aortic or mitral valve disease has become standard therapy. Likewise, promising results have been obtained for percutaneous treatment options for pathologies of the tricuspid valve, which are still under intense investigation.
Collapse
|
117
|
Bellwon P, Truisi G, Bois F, Wilmes A, Schmidt T, Savary C, Parmentier C, Hewitt P, Schmal O, Josse R, Richert L, Guillouzo A, Mueller S, Jennings P, Testai E, Dekant W. Kinetics and dynamics of cyclosporine A in three hepatic cell culture systems. Toxicol In Vitro 2015; 30:62-78. [DOI: 10.1016/j.tiv.2015.07.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2014] [Revised: 06/30/2015] [Accepted: 07/06/2015] [Indexed: 01/08/2023]
|
118
|
Bellwon P, Culot M, Wilmes A, Schmidt T, Zurich M, Schultz L, Schmal O, Gramowski-Voss A, Weiss D, Jennings P, Bal-Price A, Testai E, Dekant W. Cyclosporine A kinetics in brain cell cultures and its potential of crossing the blood–brain barrier. Toxicol In Vitro 2015; 30:166-75. [DOI: 10.1016/j.tiv.2015.01.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2014] [Revised: 11/30/2014] [Accepted: 01/05/2015] [Indexed: 02/08/2023]
|
119
|
Sand L, Scotlandi K, Berghuis D, Snaar-Jagalska B, Picci P, Schmidt T, Szuhai K, Hogendoorn P. CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients. Eur J Cancer 2015; 51:2624-33. [DOI: 10.1016/j.ejca.2015.08.020] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Revised: 08/05/2015] [Accepted: 08/21/2015] [Indexed: 11/26/2022]
|
120
|
Schmidt T, Alldinger I, Blank S, Klose J, Springfeld C, Dreikhausen L, Weichert W, Grenacher L, Bruckner T, Lordick F, Ulrich A, Büchler M, Ott K. Surgery in oesophago-gastric cancer with metastatic disease: Treatment, prognosis and preoperative patient selection. Eur J Surg Oncol 2015. [DOI: 10.1016/j.ejso.2015.05.005] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023] Open
|
121
|
Tsui-Caldwell Y, Christensen Z, Oleson D, Leete R, Gonzales J, Skiles M, Smith A, Schmidt T, Schmidt M, Neves W, Bigler E. A-62Schelten et al. Ratings for Mesial Temporal Lobe Atrophy in the Social Outcomes of Brain Injury in Kids. Arch Clin Neuropsychol 2015. [DOI: 10.1093/arclin/acv047.62] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
122
|
Klose J, Eissele J, Volz C, Schmitt S, Schmidt T, Schneider M, Büchler M, Ulrich A. 117 Salinomycin interferes with Wnt signaling in CD133+/- colorectal cancer cells and inhibits tumour growth in vivo. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)30015-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
123
|
Sand LGL, Jochemsen AG, Beletkaia E, Schmidt T, Hogendoorn PCW, Szuhai K. Novel splice variants of CXCR4 identified by transcriptome sequencing. Biochem Biophys Res Commun 2015; 466:89-94. [PMID: 26321665 DOI: 10.1016/j.bbrc.2015.08.113] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2015] [Accepted: 08/25/2015] [Indexed: 10/23/2022]
Abstract
Chemokine receptor CXCR4 is involved in tumor growth, angiogenesis and metastasis. Its function is regulated in many ways and one of them is alternative splicing. We identified two novel coding splice variants (CXCR4-3 and CXCR4-4) of CXCR4 in Ewing sarcoma (EWS) cell lines by whole transcriptome sequencing and validated these with reverse transcriptase- PCR and Sanger sequencing. The novel splice variants were expressed at RNA level in Ewing sarcoma samples and in other tumor cell lines and placenta, but not in lung. Due to inclusion of an additional exon the new isoforms have a 70 and 33 amino acid elongation of the N-terminal end of CXCR4. For validation at protein and functional level, the identified isoforms and normal CXCR4 were cloned into an EYFP tagged vector and ectopically expressed in HEK293T cell line and EWS cell line A673. Of the novel isoforms CXCR4-3 showed cell membrane localization and a functional response after addition of CXCR4 ligand CXCL12a. CXCR4-4 showed strong cytoplasmic accumulation and no response to ligand treatment. The role of the newly discovered isoforms in CXCR4 signaling is likely to be limited. Our data stresses the importance of functional validation of newly identified isoforms.
Collapse
|
124
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Archinger M, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Tjus JB, Becker KH, Beiser E, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Brown AM, Buzinsky N, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Christy B, Clark K, Classen L, Coenders S, Cowen DF, Silva AHC, Daughhetee J, Davis JC, Day M, de André JPAM, De Clercq C, Dembinski H, De Ridder S, Desiati P, de Vries KD, de Wasseige G, de With M, DeYoung T, Díaz-Vélez JC, Dumm JP, Dunkman M, Eagan R, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fadiran O, Fahey S, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Fuchs T, Glagla M, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Gier D, Gladstone L, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grant D, Gretskov P, Groh JC, Groß A, Ha C, Haack C, Ismail AH, Hallgren A, Halzen F, Hansmann B, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfe K, Homeier A, Hoshina K, Huang F, Huber M, Huelsnitz W, Hulth PO, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jero K, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Keivani A, Kelley JL, Kemp J, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Kohnen G, Kolanoski H, Konietz R, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll G, Kroll M, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leuner J, Lünemann J, Madsen J, Maggi G, Mahn KBM, Maruyama R, Mase K, Matis HS, Maunu R, McNally F, Meagher K, Medici M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Middell E, Middlemas E, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Olivas A, Omairat A, O'Murchadha A, Palczewski T, Paul L, Pepper JA, de Los Heros CP, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Relich M, Resconi E, Rhode W, Richman M, Richter S, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sabbatini L, Sander HG, Sandrock A, Sandroos J, Sarkar S, Schatto K, Scheriau F, Schimp M, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Seckel D, Seunarine S, Shanidze R, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stahlberg M, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stößl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, van Eijndhoven N, Vandenbroucke J, van Santen J, Vanheule S, Veenkamp J, Vehring M, Voge M, Vraeghe M, Walck C, Wallraff M, Wandkowsky N, Weaver C, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Zoll M. Evidence for Astrophysical Muon Neutrinos from the Northern Sky with IceCube. PHYSICAL REVIEW LETTERS 2015; 115:081102. [PMID: 26340177 DOI: 10.1103/physrevlett.115.081102] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/14/2015] [Indexed: 05/16/2023]
Abstract
Results from the IceCube Neutrino Observatory have recently provided compelling evidence for the existence of a high energy astrophysical neutrino flux utilizing a dominantly Southern Hemisphere data set consisting primarily of ν(e) and ν(τ) charged-current and neutral-current (cascade) neutrino interactions. In the analysis presented here, a data sample of approximately 35,000 muon neutrinos from the Northern sky is extracted from data taken during 659.5 days of live time recorded between May 2010 and May 2012. While this sample is composed primarily of neutrinos produced by cosmic ray interactions in Earth's atmosphere, the highest energy events are inconsistent with a hypothesis of solely terrestrial origin at 3.7σ significance. These neutrinos can, however, be explained by an astrophysical flux per neutrino flavor at a level of Φ(E(ν))=9.9(-3.4)(+3.9)×10(-19) GeV(-1) cm(-2) sr(-1) s(-1)(E(ν)/100 TeV(-2), consistent with IceCube's Southern-Hemisphere-dominated result. Additionally, a fit for an astrophysical flux with an arbitrary spectral index is performed. We find a spectral index of 2.2(-0.2)(+0.2), which is also in good agreement with the Southern Hemisphere result.
Collapse
|
125
|
Aartsen MG, Abraham K, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Altmann D, Anderson T, Archinger M, Arguelles C, Arlen TC, Auffenberg J, Bai X, Barwick SW, Baum V, Bay R, Beatty JJ, Tjus JB, Becker KH, Beiser E, BenZvi S, Berghaus P, Berley D, Bernardini E, Bernhard A, Besson DZ, Binder G, Bindig D, Bissok M, Blaufuss E, Blumenthal J, Boersma DJ, Bohm C, Börner M, Bos F, Bose D, Böser S, Botner O, Braun J, Brayeur L, Bretz HP, Brown AM, Buzinsky N, Casey J, Casier M, Cheung E, Chirkin D, Christov A, Christy B, Clark K, Classen L, Coenders S, Cowen DF, Silva AHC, Daughhetee J, Davis JC, Day M, André JPAMD, Clercq CD, Dembinski H, Ridder SD, Desiati P, Vries KDD, Wasseige GD, With MD, DeYoung T, Díaz-Vélez JC, Dumm JP, Dunkman M, Eagan R, Eberhardt B, Ehrhardt T, Eichmann B, Euler S, Evenson PA, Fadiran O, Fahey S, Fazely AR, Fedynitch A, Feintzeig J, Felde J, Filimonov K, Finley C, Fischer-Wasels T, Flis S, Fuchs T, Gaisser TK, Gaior R, Gallagher J, Gerhardt L, Ghorbani K, Gier D, Gladstone L, Glagla M, Glüsenkamp T, Goldschmidt A, Golup G, Gonzalez JG, Goodman JA, Góra D, Grant D, Gretskov P, Groh JC, Gross A, Ha C, Haack C, Ismail AH, Hallgren A, Halzen F, Hansmann B, Hanson K, Hebecker D, Heereman D, Helbing K, Hellauer R, Hellwig D, Hickford S, Hignight J, Hill GC, Hoffman KD, Hoffmann R, Holzapfel K, Homeier A, Hoshina K, Huang F, Huber M, Huelsnitz W, Hulth PO, Hultqvist K, In S, Ishihara A, Jacobi E, Japaridze GS, Jero K, Jurkovic M, Kaminsky B, Kappes A, Karg T, Karle A, Kauer M, Keivani A, Kelley JL, Kemp J, Kheirandish A, Kiryluk J, Kläs J, Klein SR, Kohnen G, Kolanoski H, Konietz R, Koob A, Köpke L, Kopper C, Kopper S, Koskinen DJ, Kowalski M, Krings K, Kroll G, Kroll M, Kunnen J, Kurahashi N, Kuwabara T, Labare M, Lanfranchi JL, Larson MJ, Lesiak-Bzdak M, Leuermann M, Leuner J, Lünemann J, Madsen J, Maggi G, Mahn KBM, Maruyama R, Mase K, Matis HS, Maunu R, McNally F, Meagher K, Medici M, Meli A, Menne T, Merino G, Meures T, Miarecki S, Middell E, Middlemas E, Miller J, Mohrmann L, Montaruli T, Morse R, Nahnhauer R, Naumann U, Niederhausen H, Nowicki SC, Nygren DR, Obertacke A, Olivas A, Omairat A, O’Murchadha A, Palczewski T, Paul L, Pepper JA, Heros CPDL, Pfendner C, Pieloth D, Pinat E, Posselt J, Price PB, Przybylski GT, Pütz J, Quinnan M, Rädel L, Rameez M, Rawlins K, Redl P, Reimann R, Relich M, Resconi E, Rhode W, Richman M, Richter S, Riedel B, Robertson S, Rongen M, Rott C, Ruhe T, Ruzybayev B, Ryckbosch D, Saba SM, Sabbatini L, Sander HG, Sandrock A, Sandroos J, Sarkar S, Schatto K, Scheriau F, Schimp M, Schmidt T, Schmitz M, Schoenen S, Schöneberg S, Schönwald A, Schukraft A, Schulte L, Seckel D, Seunarine S, Shanidze R, Smith MWE, Soldin D, Spiczak GM, Spiering C, Stahlberg M, Stamatikos M, Stanev T, Stanisha NA, Stasik A, Stezelberger T, Stokstad RG, Stössl A, Strahler EA, Ström R, Strotjohann NL, Sullivan GW, Sutherland M, Taavola H, Taboada I, Ter-Antonyan S, Terliuk A, Tešić G, Tilav S, Toale PA, Tobin MN, Tosi D, Tselengidou M, Unger E, Usner M, Vallecorsa S, Vandenbroucke J, Eijndhoven NV, Vanheule S, Santen JV, Veenkamp J, Vehring M, Voge M, Vraeghe M, Walck C, Wallace A, Wallraff M, Wandkowsky N, Weaver C, Wendt C, Westerhoff S, Whelan BJ, Whitehorn N, Wichary C, Wiebe K, Wiebusch CH, Wille L, Williams DR, Wissing H, Wolf M, Wood TR, Woschnagg K, Xu DL, Xu XW, Xu Y, Yanez JP, Yodh G, Yoshida S, Zarzhitsky P, Zoll M. A COMBINED MAXIMUM-LIKELIHOOD ANALYSIS OF THE HIGH-ENERGY ASTROPHYSICAL NEUTRINO FLUX MEASURED WITH ICECUBE. ACTA ACUST UNITED AC 2015. [DOI: 10.1088/0004-637x/809/1/98] [Citation(s) in RCA: 288] [Impact Index Per Article: 32.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|